It was shown that CPT-11 activates transcription factor AP-1 to regulate MSH2 expression through ERK1/2 and Akt signaling in CRC DLD-1 cells and this MSH2 induction could further attenuate the sensitivity of DLD-1 to CPT-11. This evidence concerns the gene MAPK3 and colorectal carcinoma.